Vaccine News and Research

Latest Vaccine News and Research

Digital payments revolutionize health worker compensation in Africa

Campaigns in Africa to stop polio and other diseases have a more stable, better-motivated workforce thanks to WHO's collaboration with countries and partners to pay frontline health workers through their mobile phones instead of in cash.

1 Apr 2024

Research suggests booster doses may be necessary for monkeypox immunity

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that even in men who receives two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.

1 Apr 2024

Study reveals waning antibody response to monkeypox vaccine over time

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination – but in people with pre-existing immunity due to childhood smallpox vaccination in childhood, antibody levels remain high in almost all cases.

1 Apr 2024

Case study: Monkeypox breakthrough infection in fully vaccinated individual

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain (27-30 April) details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a 'breakthrough' mpox infection in January 2024.

1 Apr 2024

Four years after shelter-in-place, covid-19 misinformation persists

From spring break parties to Mardi Gras, many people remember the last major “normal” thing they did before the novel coronavirus pandemic dawned, forcing governments worldwide to issue stay-at-home advisories and shutdowns.

1 Apr 2024

Second-generation melanoma vaccine prolongs survival of patients with skin cancer

A second-generation melanoma vaccine being developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows.

29 Mar 2024

Introducing CoViNet: WHO's global network for coronavirus expertise

WHO has launched a new network for coronaviruses, CoViNet, to facilitate and coordinate global expertise and capacities for early and accurate detection, monitoring and assessment of SARS-CoV-2, MERS-CoV and novel coronaviruses of public health importance.

29 Mar 2024

WHO releases an investment case for TB screening and preventive treatment

Ahead of World Tuberculosis (TB) Day, which is marked on 24 March, WHO has released an investment case for TB screening and preventive treatment. A modeling study developed with Governments of four countries - Brazil, Georgia, Kenya and South Africa - highlights the impact to be achieved from expanding TB screening and preventive treatment.

29 Mar 2024

Global efforts urged to stem rising cholera threat

Immediate action is needed to stem an unprecedented multi-year upsurge in cholera cases worldwide, according to the International Coordinating Group (ICG) on Vaccine Provision.

28 Mar 2024

Major global commitments announced to eradicate cervical cancer

Governments, donors, multilateral institutions, and partners today announced major new policy, programmatic and financial commitments, including nearly US$ 600 million in new funding, to eliminate cervical cancer.

28 Mar 2024

Higher COVID-19 hospitalization and mortality rates in MS patients despite vaccination

New real-world research being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) reveals that people living with multiple sclerosis (MS) face a much higher risk of being hospitalised and dying from COVID-19 than the general population.

28 Mar 2024

Scientists develop an mRNA technology approach to target Alzheimer’s disease

Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer's disease and other dementias.

28 Mar 2024

Antibody discovery could explain mysteries about COVID-19 and long COVID

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID.

28 Mar 2024

Global leaders set ambitious targets to end tuberculosis epidemic

World leaders at the United Nations General Assembly's High-Level Meeting on Tuberculosis have approved a Political Declaration with ambitious new targets for the next five years to advance the global efforts towards ending the TB epidemic.

28 Mar 2024

WHO recommends R21/Matrix-M vaccine for malaria prevention in children

The World Health Organization (WHO) has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children.

27 Mar 2024

MMR vaccine slashes antibiotic use in toddlers: Nordic study shines light on broader benefits

Study demonstrates that administering the MMR vaccine to children under two, following three DTaP doses, significantly reduces the need for antibiotic treatments, highlighting potential non-specific protective effects.

26 Mar 2024

Single dengue vaccine dose shows mixed results: Protection hinges on prior exposure

Study investigates the protective effects of a single CYD-TDV vaccine dose against dengue virus in Filipino children, revealing that while the vaccine does not protect children with no or one prior dengue infection, it significantly reduces infection risk in those with two or more prior infections.

26 Mar 2024